Cargando…

A Large Impact of Obesity on the Disposition of Ivermectin, Moxidectin and Eprinomectin in a Canine Model: Relevance for COVID-19 Patients

Ivermectin (IVM) and moxidectin (MOX) are used extensively as parasiticides in veterinary medicine. Based on in vitro data, IVM has recently been proposed for the prevention and treatment of COVID-19 infection, a condition for which obesity is a major risk factor. In patients, IVM dosage is based on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bousquet-Mélou, Alain, Lespine, Anne, Sutra, Jean-François, Bargues, Isabelle, Toutain, Pierre-Louis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173197/ https://www.ncbi.nlm.nih.gov/pubmed/34093195 http://dx.doi.org/10.3389/fphar.2021.666348

Ejemplares similares

Relative Neurotoxicity of Ivermectin and Moxidectin in Mdr1ab (−/−) Mice and Effects on Mammalian GABA(A) Channel Activity
por: Ménez, Cécile, et al.
Publicado: (2012)

Population Pharmacokinetic Study of Cefazolin Used Prophylactically in Canine Surgery for Susceptibility Testing Breakpoint Determination
por: Cagnardi, Petra, et al.
Publicado: (2018)

Eprinomectin and Moxidectin Resistance of Trichostrongyloids on a Goat Farm in Austria
por: Hinney, Barbara, et al.
Publicado: (2022)

Caenorhabditis elegans as a valuable model for the study of anthelmintic pharmacodynamics and drug-drug interactions: The case of ivermectin and eprinomectin
por: Suárez, Gonzalo, et al.
Publicado: (2022)

Preclinical Study of Single-Dose Moxidectin, a New Oral Treatment for Scabies: Efficacy, Safety, and Pharmacokinetics Compared to Two-Dose Ivermectin in a Porcine Model
por: Bernigaud, Charlotte, et al.
Publicado: (2016)

Anthelmintic resistance to ivermectin and moxidectin in gastrointestinal nematodes of cattle in Europe
por: Geurden, Thomas, et al.
Publicado: (2015)

Interpreting Bisphenol A Absorption in the Canine Oral Cavity: Gayrard et al. Respond
por: Gayrard, Véronique, et al.
Publicado: (2013)

First report of eprinomectin-resistant isolates of Haemonchus contortus in 5 dairy sheep farms from the Pyrénées Atlantiques département in France
por: Jouffroy, S., et al.
Publicado: (2023)

Comparison of the In vitro Activity of Five Antimicrobial Drugs against Staphylococcus pseudintermedius and Staphylococcus aureus Biofilms
por: Ferran, Aude A., et al.
Publicado: (2016)

Veterinary Medicine Needs New Green Antimicrobial Drugs
por: Toutain, Pierre-Louis, et al.
Publicado: (2016)

Implementing Precision Antimicrobial Therapy for the Treatment of Bovine Respiratory Disease: Current Limitations and Perspectives
por: Lhermie, Guillaume, et al.
Publicado: (2017)

Bacterial Species-Specific Activity of a Fluoroquinolone against Two Closely Related Pasteurellaceae with Similar MICs: Differential In Vitro Inoculum Effects and In Vivo Efficacies
por: Lhermie, Guillaume, et al.
Publicado: (2015)

Infection-stage adjusted dose of beta-lactams for parsimonious and efficient antibiotic treatments: A Pasteurella multocida experimental pneumonia in mice
por: Vasseur, Maleck V., et al.
Publicado: (2017)

Treatment of canine generalized demodicosis associated with hyperadrenocorticism with spot-on moxidectin and imidacloprid
por: Huang, Hui-Pi, et al.
Publicado: (2013)

A Randomized, Single-Ascending-Dose, Ivermectin-Controlled, Double-Blind Study of Moxidectin in Onchocerca volvulus Infection
por: Awadzi, Kwablah, et al.
Publicado: (2014)

Ivermectin and Moxidectin Can Incapacitate Different Strains of the Common Bed Bug Cimex lectularius L.: A Study
por: Sheele, Johnathan M, et al.
Publicado: (2020)

Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?
por: Concordet, Didier, et al.
Publicado: (2019)

Solvatomorphism of Moxidectin
por: Grell, Toni, et al.
Publicado: (2021)

Dynamic interactions between cephalexin and macrophages on different Staphylococcus aureus inoculum sizes: a tripartite in vitro model
por: Lallemand, Elodie Anne, et al.
Publicado: (2021)

Is Ivermectin Effective in Treating COVID-19?
por: Yang, Shuangshuang, et al.
Publicado: (2022)

Authors’ Reply to Castello-Bridoux et al.: “Comment on Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Coste et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Lechat et al.: “Levothyrox(®) New and Old Formulations: Are they Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

Why Were More Than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Nicolas: “Why Were More than 200 Subjects Required to Demonstrate the Bioequivalence of a New Formulation of Levothyroxine with an Old One?”
por: Concordet, Didier, et al.
Publicado: (2019)

Authors’ Reply to Yu et al.: “Levothyrox(®) New and Old Formulations: Are They Switchable for Millions of Patients?”
por: Concordet, Didier, et al.
Publicado: (2019)

The effect of moxidectin 0,1% vs ivermectin 0,08% on milk production in sheep naturally infected by gastrointestinal nematodes
por: Cringoli, Giuseppe, et al.
Publicado: (2009)

First assessment of the comparative toxicity of ivermectin and moxidectin in adult dung beetles: Sub-lethal symptoms and pre-lethal consequences
por: Verdú, José R., et al.
Publicado: (2018)

In vitro Degradation of Antimicrobials during Use of Broth Microdilution Method Can Increase the Measured Minimal Inhibitory and Minimal Bactericidal Concentrations
por: Lallemand, Elodie A., et al.
Publicado: (2016)

Comparison of in vitro static and dynamic assays to evaluate the efficacy of an antimicrobial drug combination against Staphylococcus aureus
por: Broussou, Diane C., et al.
Publicado: (2019)

Biased computation of probability of target attainment for antimicrobial drugs
por: Toutain, Pierre‐Louis, et al.
Publicado: (2023)

Comment on “In Vitro Effects of Bisphenol A β-D-Glucuronide (BPA-G) on Adipogenesis in Human and Murine Preadipocytes”
por: Gayrard, Véronique, et al.
Publicado: (2015)

Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d’Ivoire: A randomized controlled superiority study
por: Bjerum, Catherine M., et al.
Publicado: (2023)

Heat pretreatment of canine samples to evaluate efficacy of imidacloprid + moxidectin and doxycycline in heartworm treatment
por: Bendas, Alexandre José Rodrigues, et al.
Publicado: (2017)

High Bioavailability of Bisphenol A from Sublingual Exposure
por: Gayrard, Véronique, et al.
Publicado: (2013)

En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach
por: Toutain, Pierre-Louis, et al.
Publicado: (2017)

Author Correction: First assessment of the comparative toxicity of ivermectin and moxidectin in adult dung beetles: Sub-lethal symptoms and pre-lethal consequences
por: Verdú, José R., et al.
Publicado: (2019)

Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells
por: Dinesh Kumar, Nilima, et al.
Publicado: (2022)

Ivermectin as a potential treatment for COVID-19?
por: Chosidow, Olivier, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rshjneofaf3qqt3jm7b1vvqu8f